HLA-C and cancer: Chimeric antigen receptors, or CARs, link the single chain variable fragment of an antibody to T cell intracellular activation and stimulatory domains, allowing T cells to recognize cancer cells independently of major histocompatibility complex (MHC) restriction and perform cytotoxic functions [6].